Abstract: α-Synuclein, a natively unfolded protein aggregation which is implicated in the pathogenesis of Parkinson's disease and several other neurodegenerative diseases, is known to interact with a great number of unrelated proteins. Some of these proteins, such as ß-synuclein and DJ-1, were shown to inhibit α-synuclein aggregation in vitro and in vivo therefore acting as chaperones. Since calbindin-D 28K is co-localized with Ca 2+ neuronal membrane pumps, and since α-synuclein is also found in the membrane proximity, these two proteins can potentially interact in vivo. Here we show that calbindin-D28K interacts with α-synuclein and inhibits its fibrillation in a calciumdependent manner, therefore potentially acting as a calcium-dependent chaperone.
Introduction
Parkinson's Disease (PD) is characterized by loss of dopaminergic neurons and the presence of cytosolic filamentous inclusions known as Lewy bodies (LBs) and Lewy neurites (LNs) [1, 2] . LBs have a dense fibrillar core that is rich in cross-β-structure. α-Synuclein, a small (14 kDa), abundant, and highly conserved presynaptic protein [3] [4] [5] , is the major fibrillar component of LBs and LNs in PD and several neurodegenerative disorders [6] [7] [8] . Aggregation and fibrillation of α-synuclein has been implicated in PD and other synucleinopathies, and it was proposed that some transient oligomers, protofibrils or mature fibrils might be toxic to neurons [9] . α-Synuclein was estimated to account for as much as 1% of the total protein in soluble cytosolic brain fractions [5] . Although the precise function of this protein remains elusive its primary localization near the nerve terminals in the central nervous system and the close association of α-synuclein with vesicular structures, has led to the hypothesis that it may regulate vesicular release and/or turnover, and synaptic function in the central nervous system [10] [11] [12] [13] [14] . However, there is no strong evidence supporting the constitutive association of α-synuclein with synaptic vesicles in vivo [5, 14, 15] . Structurally, purified α-synuclein is a typical natively unfolded protein [16, 17] , but being highly pliable [18] , it tends to change its "natively unfolded" conformation toward either fibrils that are rich in β-sheet or α-helical structure on binding to lipid membranes in vitro [13, [19] [20] [21] [22] [23] [24] [25] [26] [27] . Since α-synuclein appears to be mostly natively unfolded, some other proteins might regulate the conformations and aggregation of α-synuclein in vivo. In fact, α-synuclein was shown to interact with at least 50 binding partners including some other proteins [28] , whereas a recent proteomic analysis using a SILAC technique (stable isotope labeling by amino acids in cell culture) identified 587 proteins involved in the formation of complexes with α-synuclein in dopaminergic rat mesencephalic/neuroblastoma hybrid (MES) cells, with 141 proteins displaying significant changes in their relative abundance (increase or decrease) after the MES cell were treated with rotenone [29] . Among several proteins that have been reported to interact with α-synuclein, tau [30, 31] , synphilin-1 [32, 33] , and calmodulin [34] , were shown to accelerate α-synuclein fibrillation, whereas β-synuclein [35, 36] and DJ-1 [37, 38] effectively inhibited the fibrillation process.
Calbindin-D 28K is a calcium binding protein that is widely expressed in Ca 2+ transporting tissues such as epithelial-absorptive cells of the intestine and the distal tubular epithelial cells of the kidney [39, 40] . Calbindin-D 28K was also found in the nervous system and it was suggested to co-localize with plasma membrane Ca 2+ pumps [41] [42] [43] . The function of calbindin-D 28K is dependent on the intracellular Ca 2+ concentrations and it was shown that Ca 2+ binding to calbindin-D 28K induced local structure changes around aromatic residues while no significant secondary structural changes were observed [44] . Calbindin-D 28K was also implicated in PD since it was found that the dopaminergic neurons of the substantia nigra pars compacta (A9) expressing calbindin-D 28K were more resistant to cell death than the neurons that do not express calbindin-D 28K in PD and in animal models [45] [46] [47] [48] [49] . To understand whether the protection of neurons against PD by expressing calbindin-D 28K is related to α-synuclein we investigated the interaction of these two proteins in vitro. Here we show that calbindin-D 28K is able to interact and co-aggregate with α-synuclein, significantly inhibiting α-synuclein fibrillation. Therefore, calbindin-D 28K can act as a chaperone, efficiently suppressing the process of α-synuclein fibril formation.
Experimental Procedures

Materials
Recombinant human α-synuclein was expressed in Escherichia coli and purified similarly as described previously [50] . As previously described [44] , the full length rat brain calbindin-D 28K was fused with Glutathione-S-transferases (GST) and was expressed in Escherichia coli BL 21 cells. GST-calbindin fusion proteins were cleaved with thrombin (Sigma). GSTrap
TM
FF and HiTrap
TM
Benzamidine FF(HS) columns were used to separate Calbindin-D 28K from GST and thrombin respectively. The purified calbindin-D 28K has a molecular weight of ~30 kDa. All other chemicals were analytical grade and purchased from Fisher chemicals or EM science.
Labeling of α-synuclein or Calbindin-D 28K
by FITC 
Fibril formation and ThT assay
Fibril formation was monitored by characteristic changes in thioflavine T (ThT) fluorescence using a Fluoroskan Ascent CF plate reader (Labsystems, Inc.). Protein solutions with 70 µM α-synuclein, 66 µM Calbindin-D 28K , together or separately, were incubated in 100 mM NaCl, 20 mM Tris buffer (pH 7.2) and 20 µM ThT on a 96-well plate, each well containing a 1/8 inch diameter Teflon sphere bead. The plate was incubated at 37°C with shaking at 120 rpm, 20 mm diameter or 600 rpm, 2 mm diameter. The fluorescence was measured at 30 min intervals with excitation at 450 nm and emission at 485 nm. Data from six wells were averaged and plotted as a function of time, then fitted to a sigmoidal curve using Sigmaplot software. Lag times were calculated based on the equation described previously [17] .
Far-UV circular dichroism (CD) measurements
Far-UV CD spectra were collected with an Aviv 60DS spectropolarimeter at 1 nm intervals, 1.5 nm bandwidth and averaging time of 1.0 second. Measurements were performed in a 0.02 cm cell at room temperature over the range 190-250 nm. Five scans were applied continuously and the data were averaged.
Size-exclusion HPLC and FPLC measurements
All samples contained 5 mM DTT to reduce disulfide bonds. Samples were freshly made and centrifuged for 20 min at 14,000 rpm to remove any insoluble materials and then directly loaded onto SEC column. For HPLC, 15 µL of α-synuclein (280 µM), calbindin (33 or 66 µM), or their mixture solutions were eluted from a TSK-GEL G2000SW XL size-exclusion column (7.8 mm ID × 30 cm) at a flow rate of 0.5 mL/min in 40 mM phosphate buffer (pH 7.2). HPLC was performed using Waters 2695 separations module with a Waters 996 Photodiode Array (PDA) detector, and data were collected and analyzed by Millennium software. Absorbance of the eluent was monitored over the wavelength range from 220 to 450 nm with bandwidth of 1.2 nm.
Examining co-aggregation of α-synuclein and calbindin-D 28K
Samples of incubated α-synuclein-calbindin-D 28K mixture were collected and centrifuged for 20 min at 14,000 rpm to precipitate insoluble materials. The resulting pellets were carefully re-suspended in 100 mM NaCl, 20 mM Tris buffer (pH 7.2). These suspensions were centrifuged again for 20 min at 14,000 rpm. This re-suspension-re-centrifugation cycle was repeated 3 times. Then, the washed pellets were analyzed by the SDS-PAGE.
SDS-PAGE and native gel electrophoresis measurements
Samples for sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) gel electrophoresis were boiled in water bath for 10 min in 2% SDS and dithiothreitol (DTT) was added to samples (final DTT concentration 5 mM) prior to electrophoretic separation. DTT was used to prevent disulfide bond formation. PhastSystem on 8-25% gradient gels (Amersham Biosciences) were used and experiments were run with SDS buffer strips for 30 min at 250V. Gels were stained with Coomassie blue. Samples for native gel were directly loaded on 8-25% gradient gels and experiments were run with native buffer strips under similar conditions with SDS-PAGE.
Mass spectrometry
Samples for MS analysis were desalted with C8 reverse phase column and eluted out with 4 acetonitrile : 1 H 2 O (pH adjusted to 2.0 by trifluoroacetic acid) solution.
The desalted solution was directly loaded onto Mass spectrometer. Mass spectra were obtained using a MicroMass Quattro II electrospray mass spectrometer operating in positive ion mode. Injection was carried out using a syringe pump (Harvard Apparatus, Holliston, MA) at a flow-rate of 20 μl/min. The source temperature was set to 80°C and the capillary voltage was 3.25 kV. Protein molecular weight was determined from mass-tocharge ratios by MassLynx software.
Electron Microscopy Measurements
Samples electron microscopy (EM) were deposited on the carbon-coated pioloform 300 mesh copper grids and negatively stained with 1% (w/v) aqueous uranyl acetate. EM images were obtained on a JEOL JEM-100B transmission electron microscope operated at 80 kV.
Results and Discussion
Probing the interactions between α-synuclein and Calbindin-D 28K by fluorescence techniques
Two approaches were used to probe the interactions between α-synuclein and calbindin-D 28K . In the first approach, changes in the intrinsic tryptophan (Trp) fluorescence of calbindin-D 28K were monitored as function of increasing α-synuclein concentration. Since α-synuclein does not have tryptophans whereas rat brain calbindin-D 28K has two tryptophan residues (Trp20 and Trp107), this approach reports on the bindinginduced changes in the local environment of calbindin-D 28K Trp residues. In the second approach, changes in the extrinsic fluorescence were used to detect binding. Here, FITC-labeled α-synuclein or calbindin-D 28K were titrated with the increasing concentrations of the unlabeled partner.
The maximum wavelength of calbindin-D 28K Trp fluorescence was at 332 nm, indicating considerable protection of Trp residues from the solvent, being buried inside the calbindin-D 28K . Figure 1A shows that the intrinsic fluorescence of calbindin-D 28K was not affected by its interaction with α-synuclein suggesting that the α-synuclein binding did not affect the overall structure of calbindin-D 28K .
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( max) On the contrary, the fluorescence parameters of the FITC-labeled calbindin-D 28K were sensitive to its interaction with α-synuclein. In fact, the intensity of FITC fluorescence increased in an exponential rise to maximum mode reaching saturation after six or more molar equivalents of α-synuclein were added to the FITC-labeled calbindin-D 28K solution ( Figure 1B ). This clearly indicated that α-synuclein did interact with calbindin-D 28K and that one calbindin-D 28K molecule has multiple α-synuclein binding sites. Similarly, the fluorescence intensity of FITC-labeled α-synuclein also increased in an exponential rise to maximum mode reaching plateau when two or more molar equivalents of calbindin-D 28K were present in solution ( Figure 1C) , suggesting that α-synuclein might have two calbindin-D 28K interacting sites. Importantly, CaCl 2 seems to strengthen this interaction between α-synuclein and calbindin-D 28K since the addition of CaCl 2 to the reaction mixture led to a further increase in the FITC-labeled α-synuclein fluorescence intensity compared to the effect of calbindin-D 28K alone ( Figure 1D ).
Interaction of calbindin-D 28K and α-synuclein
led to negligible changes in protein secondary structure
The fact that α-synuclein binding did not affect the global structure of calbindin-D 28K was further confirmed by the far-UV CD analysis. To this end, a far-UV CD spectrum of the α-synuclein-calbindin-D 28K mixture with the molar ratio of 2:1 was compared with the weighted sum of far-UV CD spectra of these two proteins measured individually. Figure 2 represents the results of this analysis and clearly shows that the calculated and measured spectra were almost identical. This indicates that the formation of the complex between α-synuclein and calbindin-D 28K was not accompanied by noticeable changes in protein secondary structure. For calbindin-D 28K , these data support the results of the intrinsic fluorescence analysis, which indicated that the interaction of calbindin-D 28K with α-synuclein did not affect the accessibility of the calbindin Trp residues to solvent, suggesting that the overall structure of this protein in the complex was unchanged. Interestingly, even α-synuclein remained natively unfolded after the complex formation. This is an unusual but not unprecedented observation. The lack of considerable structural changes in complexes of natively unfolded proteins with their binding partners (either themselves or other proteins) was earlier observed for the caldesmon-calmodulin complex formation [51] , dimerization and oligomerization of α-synuclein [52] and for the functional self-oligomerization of intrinsically disordered cytoplasmic domains of immune receptor signaling subunits [53] [54] [55] .
Complex between α-synuclein and calbindin-D 28K is unstable
When the equimolar mixture of α-synuclein (70 µM) and calbindin-D 28K (66 µM) was analyzed by SEC HPLC, no new chromatographic peak corresponding to the α-synuclein-calbindin-D 28K complex was observed (data not shown). This suggested that this complex (if formed) was rather unstable and likely dissociated during the chromatographic process. However, when calbindin-D 28K (33 µM) was added to high α-synuclein concentrations (280 µM) a new chromatographic peak ( Figure 3 , peak c) corresponding to large oligomeric species was formed. Under these conditions, the increase of calbindin-D 28K concentration was accompanied by the increase in the oligomeric peak c intensity (data not shown). The fractions corresponding to all three peaks (peaks a, b, and c) were collected, concentrated and analyzed by SDS-PAGE. Figure 3 represents the result of this analysis and shows that the peak c mainly contained α-synuclein and very small amount of calbindin-D 28K , peak a contained only α-synuclein, whereas peak b was mainly composed of calbindin-D 28K . These results suggested that calbindin-D 28K is able to trigger the α-synuclein aggregation. SDS-PAGE analysis of peak c supported the existence of α-synuclein-calbindin-D 28K complex since both proteins were co-eluting as a single peak.
Calbindin-D 28K inhibits α-synuclein fibrillation
Fibrillation of α-synuclein (70µM) alone or in the presence of roughly molar equivalent of calbindin-D 28K (66 µM) was monitored by characteristic changes in ThT fluorescence. The presence of calbindin-D 28K clearly slowed down the α-synuclein fibrillation process. Figure 4A and Table 1 show that the α-synuclein fibrillation in the presence of calbindin-D 28K was characterized by longer lag-times and lower ThT fluorescence intensities compared to the fibrillation of α-synuclein alone ( Figure 4A and Table 1 ). At the same time, calbindin-D 28K did not affect the fibrillation elongation rates and did not form fibrils itself. Since calbindin-D 28K is a calcium-binding protein and since its function depends on calcium, the effect of calcium addition on the calbindin-D 28K fibrillation inhibitory properties was analyzed. Figure 4A shows that in the absence of calbindin-D 28K , the addition of 2 mM CaCl 2 noticeably accelerated α-synuclein fibrillation. However, when the same CaCl 2 concentration was added to the α-synuclein-calbindin-D 28K mixture, the inhibitory effects of calbindin-D 28K were further strengthened (see Figure 4A and Table 1 ). This indicates that the fibrillation inhibitory function of calbindin-D 28K is calcium dependent. To further check this hypothesis, 2 mM EDTA were added to the reaction mixtures to remove the trace amounts of calcium cation in solution. Figure 4A shows that in the absence of calbindin-D 28K the fibrillation of α-synuclein was not affected by EDTA. However, the inhibitory effects of calbindin-D 28K on α-synuclein fibrillation were noticeably decreased in the presence 1p 1s 2p 2s 3p 3s
Calbindin-D28K
Alpha-synuclein of EDTA (shorter lag-time, Figure 4A and Table 1) . At the next stage, the effect of calbindin-D 28K on the morphology of α-synuclein fibrils was analyzed by EM. Figures 4B-4D shows that the morphology and number of α-synuclein fibrils were not noticeably affected by the addition of 2 mM CaCl 2 or 2 mM EDTA when α-synuclein was incubated without calbindin-D 28K . However, Figures 4E-4G illustrate that the addition of calbindin-D 28K resulted in fewer α-synuclein fibrils and these fibrils were noticeably thinner. Normal fibrils were observed when EDTA was present, and mostly oligomers and some very short "fibrils" were found in EM images when CaCl 2 was added to the α-synuclein-calbindin-D 28K mixture. This suggests that calcium bound calbindin-D 28K is a very effective inhibitor of the α-synuclein fibril growth.
Calbindin-D 28K co-aggregates with α-synuclein
Samples of incubated α-synuclein-calbindin-D 28K mixture were centrifuged and the resulting pellets were washed by 20 mM Tris-buffer using the re-suspensionre-centrifugation cycle for 3 times. Then, the washed pellets were analyzed by the SDS-PAGE ( Figure 5 ). This analysis revealed that pellets contained both α-synuclein and calbindin-D 28K and that α-synuclein was their main component. In fact, SDS-PAGE analysis showed that pellets contained roughly 8 α-synuclein molecules per each 1 calbindin-D 28K molecule. This suggested that calbindin-D 28K co-aggregates with α-synuclein into fibrils, but not at the equimolar ratio. At this point the detailed mechanism of this co-aggregation is unknown and therefore it is difficult to conclude whether calbindin-D 28K integrates into fibril or interacts with free fibrillar ends inhibiting further fibrillar growth or is simply stuck to the fibrillar hydrophobic interfaces, which are potentially able to absorb other proteins. However, since the fibrils of α-synuclein appeared "broken" and faint when calbindin-D 28K was present ( Figure 4B-4G) , calbindin-D 28K might act as a "stopper" of fibrillation growth.
Conclusions
The natively unfolded conformation of α-synuclein in the living cells may be supported by interaction with chaperones. Some proteins, such as β-synuclein and DJ-1, have been proposed to act as such chaperones, being able to inhibit aggregation of α-synuclein in vitro and in vivo. Calbindin-D 28K was suggested to co-localize with Ca 2+ membrane pump. Therefore, calbindin-D 28K might interact with α-synuclein, which is localized close to the membrane too. Here we showed that calbindin-D 28K inhibits fibrillation of α-synuclein and calcium seems to intensify this inhibitory effect. Our data suggested that calbindin-D 28K might be considered as another chaperone inhibiting the α-synuclein aggregation in a calcium-dependent manner.
